Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Improved diagnostic tests for tuberculosis in children are needed. We hypothesized that transcriptional signatures of host blood could be used to distinguish tuberculosis from other diseases in African children who either were or were not infected with the human immunodeficiency virus (HIV). METHODS: The study population comprised prospective cohorts of children who were undergoing evaluation for suspected tuberculosis in South Africa (655 children), Malawi (701 children), and Kenya (1599 children). Patients were assigned to groups according to whether the diagnosis was culture-confirmed tuberculosis, culture-negative tuberculosis, diseases other than tuberculosis, or latent tuberculosis infection. Diagnostic signatures distinguishing tuberculosis from other diseases and from latent tuberculosis infection were identified from genomewide analysis of RNA expression in host blood. RESULTS: We identified a 51-transcript signature distinguishing tuberculosis from other diseases in the South African and Malawian children (the discovery cohort). In the Kenyan children (the validation cohort), a risk score based on the signature for tuberculosis and for diseases other than tuberculosis showed a sensitivity of 82.9% (95% confidence interval [CI], 68.6 to 94.3) and a specificity of 83.6% (95% CI, 74.6 to 92.7) for the diagnosis of culture-confirmed tuberculosis. Among patients with cultures negative for Mycobacterium tuberculosis who were treated for tuberculosis (those with highly probable, probable, or possible cases of tuberculosis), the estimated sensitivity was 62.5 to 82.3%, 42.1 to 80.8%, and 35.3 to 79.6%, respectively, for different estimates of actual tuberculosis in the groups. In comparison, the sensitivity of the Xpert MTB/RIF assay for molecular detection of M. tuberculosis DNA in cases of culture-confirmed tuberculosis was 54.3% (95% CI, 37.1 to 68.6), and the sensitivity in highly probable, probable, or possible cases was an estimated 25.0 to 35.7%, 5.3 to 13.3%, and 0%, respectively; the specificity of the assay was 100%. CONCLUSIONS: RNA expression signatures provided data that helped distinguish tuberculosis from other diseases in African children with and those without HIV infection. (Funded by the European Union Action for Diseases of Poverty Program and others).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panels containing a limited number of host biomarkers are being developed as diagnostic assays for influenza77, tuberculosis70 and bacterial sepsis78.”
From Clinical metagenomics (2019) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Self-citationPerez-Velez, C. M., & Marais, B. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1008049 · Cited by 572
Zar, H. J., Hanslo, D., Apolles, P., Swingler, G., & Hussey, G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17702-2 · Cited by 511
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Wallis, R. S., Pai, M., Menzies, D., Doherty, T. M., Walzl, G., Perkins, M. D., & Zumla, A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60359-5 · Cited by 453
Kaforou, M., Wright, V. J., Oni, T., French, N., Anderson, S. T., Bangani, N., Banwell, C. M., Brent, A. J., Crampin, A. C., Dockrell, H. M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001538 · Cited by 371
Self-citationNicol, M. P., Workman, L., Isaacs, W., Munro, J., Black, F., Eley, B., Boehme, C. C., Zemanay, W., & Zar, H. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70167-0 · Cited by 338
Self-citationChintu, C., Mudenda, V., Lucas, S., Nunn, A., Lishimpi, K., Maswahu, D., Kasolo, F., Mwaba, P., Bhat, G., Terunuma, H., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11082-8 · Cited by 333
Graham, S. M., Ahmed, T., Amanullah, F., Browning, R., Cardenas, V., Casenghi, M., Cuevas, L. E., Gale, M., Gie, R. P., Grzemska, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis008 · Cited by 325
Cited by
Items 201–300 of 384
Tornheim, J. A., Paradkar, M., Zhao, H. H., Kulkarni, V., Pradhan, N., Kinikar, A. A., Kagal, A., Gupte, N., Mave, V., Gupta, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.774043 · Cited by 14
TST positivity in household contacts of tuberculosis patients: a case-contact study in Malawi
Hector, J., Anderson, S. T. B., Banda, G. M., Kamdolozi, M., Jefferys, L. F., Shani, D., Garton, N. J., Mwale, A., Jobe, A., Davies, G., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2348-2 · Cited by 14
“One investigated childhood TB and host RNA expression [17], the other investigated bacillary elimination rates and detection of bacillary LBs in sputum of pulmonary TB patients [18].”
BackgroundSelf-citationJaved, S., Marsay, L., Wareham, A., Lewandowski, K. S., Williams, A., Dennis, M. J., Sharpe, S. A., Vipond, R., Silman, N. J., Ball, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154320 · Cited by 15
Teklu, T., Wondale, B., Taye, B., Hailemariam, M., Bekele, S., Tamirat, M., Zewude, A., Mohamed, T., Medhin, G., Legesse, M., et al. (2020) · Proteome Science · doi:10.1186/s12953-020-00165-5 · Cited by 14
“With respect to ‘omics’ screens, it was reported that transcriptional signatures distinguish active TB from LTBI [11, 12] and can predict the progression of LTBI to active TB [13].”
BackgroundChen, Y., Wang, Q., Lin, S., Lai, J., Lin, J., Ao, W., Han, X., & Ye, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.585919 · Cited by 13
Functions of exosomal non-coding RNAs to the infection with Mycobacterium tuberculosis
Wang, J., Li, Y., Wang, N., Wu, J., Ye, X., Jiang, Y., & Tang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127214 · Cited by 14
Jenum, S., Bakken, R., Sivakumaran, D., Mukherjee, A., Lodha, R., Singh, S., Singh, V., Haks, M. C., Ottenhoff, T. H. M., Kabra, S. K., et al. (2016) · Scientific Reports · doi:10.1038/srep38841 · Cited by 15
Self-citationThe TAM-TB Assay—A Promising TB Immune-Diagnostic Test With a Potential for Treatment Monitoring
Ahmed, M. I. M., Ziegler, C., Held, K., Dubinski, I., Ley‐Zaporozhan, J., Geldmacher, C., & von Both, U. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00027 · Cited by 13
“Childhood TB, particularly in its extra-pulmonary form, is very challenging to diagnose, let alone to monitor treatment response (1, 2).”
BackgroundMetabolites enhance innate resistance to human Mycobacterium tuberculosis infection
Tripathi, D., Devalraju, K. P., Neela, V. S. K., Mukherjee, T., Paidipally, P., Radhakrishnan, R. K., Dozmorov, I. M., Vankayalapati, A., Ansari, M. S., Mallidi, V., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.152357 · Cited by 12
“Most transcriptional profiling studies in nonconverters and LTBI converters have used whole blood or PBMCs without M. tuberculosis antigen stimulation (21–29), suggesting the potential for interference with conditions other than M. tuberculosis exposure.”
Kim, C. H., Choi, G., & Lee, J. (2023) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2022.0152 · Cited by 12
What is New in the Diagnosis of Childhood Tuberculosis?
Rodrigues, C. S., & Singhal, T. (2024) · The Indian Journal of Pediatrics · doi:10.1007/s12098-023-04992-0 · Cited by 15
Rajamanickam, A., Daniel, E. A., Dasan, B., Thiruvengadam, K., Padmapriyadarsini, C., Gaikwad, S., Pattabiraman, S., Bhanu, B., Sivaprakasam, A., Kulkarni, V., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae365 · Cited by 12
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Viz-Lasheras, S., Gómez‐Carballa, A., Pardo‐Seco, J., Bello, X., Calle, I. R., Dacosta-Urbieta, A. I., Kaforou, M., Habgood-Coote, D., Cunnington, A. J., Emonts, M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.111747 · Cited by 16
Self-citationRayment, J. H., Guthrie, J. L., Lam, K., Whelan, M., Lee, B., Jamieson, F., & Kitai, I. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000915 · Cited by 13
“disease could represent a selection bias within our study because of the fact that we included only culture-positive patients, and the yield of respiratory specimen culture in pediatric TB is low.(1,29,30)”
BackgroundDomaszewska, T., Żyła, J., Otto, R., Kaufmann, S. H. E., & Weiner, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.694680 · Cited by 14
“Accession number Citation Study location Number of cases GSE19491 (3) London, South Africa 54 TB 96 OD 93 CTRL GSE47673 (6) Malawi, South Africa 215 TB 194 OD 175 CTRL GSE28623 (7) The Gambia 46 TB 62 CTRL GSE34608 (10) Germany 8 TB 18 sarcoidosis 18 CTRL GSE42834 (4) London 35 TB 91 OD 113 CTRL GSE39941 (48) South Af…”
InfluentialLyu, M., Zhou, J., Zhou, Y., Chong, W., Xu, W., Lai, H., Niu, L., Hai, Y., Yao, X., Gong, S., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01346-2 · Cited by 12
Predicting active tuberculosis progression by RNA analysis
Levin, M., & Kaforou, M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00165-3 · Cited by 12
Self-citationAccelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers
Kaufmann, S. H. E., Weiner, J. M., & Maertzdorf, J. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1341316 · Cited by 13
“in childhood cohorts [58] and in relation to HIV coinfection [59,60].”
BackgroundImpact of the GeneXpert MTB/RIF Technology on Tuberculosis Control
Stevens, W. S., Scott, L. E., Noble, L. D., Gous, N. M., & Dheda, K. U. J. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch18 · Cited by 16
EFIS lecture. Immune response to tuberculosis: How to control the most successful pathogen on earth
Kaufmann, S. H. E. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.05.006 · Cited by 15
Applications of gene pair methods in clinical research: advancing precision medicine
Wu, C., Xie, X., Yang, X., Du, M., Lin, H., & Huang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00263-w · Cited by 10
“GBP6 , a member of the guanylate-binding protein family, plays a critical role in innate immunity, and several studies have reported its association with PTB and can be used as a biomarker [146–148].”
Understanding immune protection against tuberculosis using RNA expression profiling
von Both, U., Kaforou, M., Levin, M., & Newton, S. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.025 · Cited by 11
Self-citationHuman Biomarkers: Can they help us to Develop a new Tuberculosis Vaccine?
Fletcher, H. A., & Dockrell, H. M. (2016) · Future Microbiology · doi:10.2217/fmb.16.15 · Cited by 14
Self-citationUpdate on trends in childhood tuberculosis
Fry, S., Barnabas, S. L., & Cotton, M. F. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000581 · Cited by 10
Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum
Dupnik, K. M., Bean, J. M., Lee, M. H., Juste, M. A. J., Skrabanek, L. A., Rivera, V. R., Vorkas, C. K., Pape, J. W., Fitzgerald, D. W., & Glickman, M. S. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.17.0855 · Cited by 12
Host transcriptional signatures as predictive markers of infection in children
Mejías, A., Cohen, S., Glowinski, R. M., & Ramilo, O. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000750 · Cited by 11
“Importantly, the genomic score was superior at identifying culture confirmed TB than traditional diagnostic tools such as the Xpert MTB/RIF assay, interferon-g release assays (IGRA) or C-reactive protein [13].”
BackgroundPersonalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
Kumar, K., & Kon, O. M. (2021) · Microorganisms · doi:10.3390/microorganisms9112220 · Cited by 11
Challenges in childhood tuberculosis
Schaaf, H. S., Marais, B. J., Carvalho, I., & Seddon, J. A. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10021817 · Cited by 12
Liu, Y., Zhang, L., Wu, F., Liu, Y., Li, Y., & Chen, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1273140 · Cited by 10
Stein, C. M. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00204-z · Cited by 12
Roy, R. B., Sambou, B., Uhía, I., Roetynck, S., Robertson, B. D., & Kampmann, B. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00151 · Cited by 12
“Studying whole blood in paediatric populations with tuberculosis has highlighted distinct gene expression signatures with diagnostic potential (47).”
BackgroundMendelsohn, S. C., Verhage, S., Mulenga, H., Scriba, T. J., & Hatherill, M. (2023) · Gates Open Research · doi:10.12688/gatesopenres.14327.1 · Cited by 10
Gupton, M., & Burns, J. D. (2023) · EFORT Open Reviews · doi:10.1530/eor-22-0136 · Cited by 12
“The presence of host genetic biomarkers associated with the expression of specific immune-modulating components such as cytokines, chemokines, and interferons is associated with different pathogenic processes (2, 20, 65, 66, 67, 68, 69, 70).”
BackgroundChannon‐Wells, S., Habgood-Coote, D., Vito, O., Galassini, R., Wright, V. J., Brent, A., Heyderman, R. S., Anderson, S. T. B., Eley, B., Martinón‐Torres, F., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05241-4 · Cited by 8
“Briefly, the signature was generated by randomly splitting the discovery cohort described in the Anderson et al. study [22] into training (80”
BackgroundMethodInfluentialSelf-citationKalesinskas, L., Gupta, S., & Khatri, P. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010260 · Cited by 10
Yang, B., Zhai, F., Yu, S., An, H., Cao, Z., Liu, Y., Wang, R., & Cheng, X. (2022) · Current Medical Science · doi:10.1007/s11596-022-2649-6 · Cited by 8
Gao, Y., & Sun, F. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010608 · Cited by 11
Contribution and Future of High-Throughput Transcriptomics in Battling Tuberculosis
Martínez-Pérez, A., Estévez, O., & González‐Fernández, Á. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.835620 · Cited by 11
Siljan, W. W., Sivakumaran, D., Ritz, C., Jenum, S., Ottenhoff, T. H. M., Ulvestad, E., Holter, J. C., Heggelund, L., & Grewal, H. M. S. (2022) · Biomarker Insights · doi:10.1177/11772719221099130 · Cited by 10
Self-citationA curated transcriptome dataset collection to investigate the immunobiology of HIV infection
Blažková, J., Boughorbel, S., Presnell, S., Quinn, C., & Chaussabel, D. (2016) · F1000Research · doi:10.12688/f1000research.8204.1 · Cited by 8
(2016) · Molecular Microbiology · doi:10.1128/9781555819071.ch6 · Cited by 10
INCREASING THE RISK OF CORRUPTION ACTIVITIES DURING A COVID-19 PANDEMIC
Terziev, V. K., Georgiev, M. P., Bankov, S., & Ministry of Interior (Sofia, B. (2017) · International scientific journal Internauka · doi:10.25313/2520-2057-2020-12-6218 · Cited by 14
Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures
Suliman, S., Jaganath, D., & DiNardo, A. R. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad270 · Cited by 6
Devlin, J. C., Zwack, E. E., Tang, M. S., Li, Z., Fenyö, D., Torres, V. J., Ruggles, K. V., & Loke, P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901133 · Cited by 8
Tuberculosis in Children and Adolescents
Whittaker, E., Welch, S. B., Cohen, J., & Seddon, J. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-75509-6_8 · Cited by 7
Serologic Responses in Childhood Pulmonary Tuberculosis
Nonyane, B. A. S., Nicol, M. P., Andreas, N. J., Rimmele, S., Schneiderhan‐Marra, N., Workman, L., Perkins, M. D., Joos, T. O., Broger, T., Ellner, J. J., et al. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001683 · Cited by 10
Diagnosis of Childhood Tuberculosis
Togun, T. O., Kampmann, B., & Pai, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64157-0 · Cited by 9
“A TB-specific whole blood 51-transcript signature with reasonable diagnostic accuracy in distinguishing TB from other diseases with similar clinical features was identified in HIV-infected and -uninfected Africa children (Anderson et al., 2014), while Verhagen et al. Fig.”
BackgroundWhole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy
Huang, H. L., Lee, J. Y., Lo, Y., Liu, I. H., Huang, S., Huang, Y. W., Lee, M., Lee, C., Cheng, M., Lu, P. L., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac003 · Cited by 7
“Some studies have proposed gene signatures for LTBI and TB diagnosis [11-13].”
BackgroundAddressing diversity in tuberculosis using multidimensional approaches
Lerm, M., & Dockrell, H. M. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12776 · Cited by 6
Self-citationPReMS: Parallel Regularised Regression Model Search for sparse bio-signature discoveryPreprint
Hoggart, C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/355479 · Cited by 7
“…this has motivated the development of proteomic and transcriptomic signatures, for example, to diagnose tuberculosis (TB) (Kaforou et al. (2013); Anderson et al. (2014); Chegou et al. (2016)), Kawasaki disease (Jaggi et al. (2018)) and to distinguish bacterial from viral infections (Herberg et…”
BackgroundMethodInfluentialGene expression signatures identify biologically and clinically distinct tuberculosis endotypesPreprint
DiNardo, A. R., Gandhi, T., Heyckendorf, J., Grimm, S. L., Rajapakshe, K., Nishiguchi, T., Reimann, M., Kahari, J., Dlamini, Q., Lange, C. G., et al. (2020) · medRxiv · doi:10.1101/2020.05.13.20100776 · Cited by 7
Development of a four autophagy-related gene signature for active tuberculosis diagnosis
Ren, B., Jia, F., Fang, Q., Xu, J., Lin, K., Huang, R., Liu, Z., & Xing, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1600348 · Cited by 6
“Moreover, signatures with larger gene number, such as Berry393 (Berry et al., 2010) or Anderson51 (Anderson et al., 2014), may pose technical and economic challenges for PCR-based assay development.”
Poore, H., Wambi, P., Nkereuwem, E., Nakafeero, J., Gomez, M. P., Nsereko, M., Sweetser, B., Andama, A. O., Wobudeya, E., Ernst, J. D., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf445 · Cited by 6
“Child-specific TB biomarkers could further improve the accuracy of a gene signature for pediatric TB screening [14].”
Single-gene transcripts for subclinical tuberculosis: an individual participant data meta-analysis
Greenan-Barrett, J., Mendelsohn, S. C., Scriba, T. J., Noursadeghi, M., & Gupta, R. K. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101186 · Cited by 6
Diagnostics for childhood tuberculosis: a marathon rather than a sprint
Togun, T. O., & Kampmann, B. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00517-0 · Cited by 6
Sex-specific blood-derived RNA biomarkers for childhood tuberculosis
Krishnan, P., Bobak, C. A., & Hill, J. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-66946-6 · Cited by 6
The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
Reimann, M., Avsar, K., DiNardo, A. R., Goldmann, T., Günther, G., Höelscher, M., Ibraim, E., Kalsdorf, B., Kaufmann, S. H. E., Köhler, N., et al. (2025) · Pathogens and Immunity · doi:10.20411/pai.v10i1.770 · Cited by 5
Chendi, B. H., Jooste, T., Scriba, T. J., Kidd, M., Mendelsohn, S. C., Tonby, K., Walzl, G., Dyrhol‐Riise, A. M., & Chegou, N. N. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2129779 · Cited by 8
Bobak, C. A., Botha, M., Workman, L., Hill, J. E., Nicol, M. P., Holloway, J. W., Stein, D. J., Martínez, L., & Zar, H. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad268 · Cited by 8
“Gene signatures for diagnosis of pediatric TB have shown specific transcriptomic profiles associated with microbiologically confirmed or clinically diagnosed TB [7].”
InfluentialWhat’s New in the Molecular Diagnosis of Childhood Tuberculosis?
Shaikh, A., & Rodrigues, C. S. (2023) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004044 · Cited by 6
What steps do we need to take to improve diagnosis of tuberculosis in children?
Venturini, E., Remaschi, G., Berti, E., Montagnani, C., Galli, L., de Martino, M., & Chiappini, E. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1040764 · Cited by 6
“In a prospective study conducted by Anderson and colleagues in almost 3000 African children, the use of genome-wide RNA expression in host blood was examined to distinguish TB from other diseases [67].”
BackgroundGönen, M. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1311-3 · Cited by 5
“We use two publicly available datasets of HIV-infected and -uninfected individuals from South Africa and Malawi: (i) adult individuals (ADULT) [14] and (ii) pediatric individuals (PEDIATRIC) [15].”
BackgroundMethodHong, G.-H., Guan, Q., Peng, H., Luo, X.-H., & Mao, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.979213 · Cited by 6
“The GSE39941 (Anderson et al., 2014) dataset was also obtained for use as the external validation cohort.”
MethodA computational framework to improve cross-platform implementation of transcriptomics signatures
Kreitmann, L., D’Souza, G., Miglietta, L., Vito, O., Jackson, H., Habgood-Coote, D., Levin, M., Holmes, A. H., Kaforou, M., & Rodríguez-Manzano, J. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105204 · Cited by 8
Self-citationSun, J., Shi, Q., Chen, X., & Liu, R. (2019) · Briefings Bioinform. · doi:10.1093/bib/bbz127 · Cited by 5
Xie, L., Zhu, G., Long, S., Wang, M., Cheng, X., Dong, Y., Wang, C., & Wang, G. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2380797 · Cited by 5
“Within the recent decade, the utilization of high-throughput sequencing and microarray-based approach in MtB-infected individuals has provided huge data sources for the detection of potential biomarkers of different tuberculosis infection status [11–13].”
BackgroundEarly Identification of Progressive TB Disease Using Host Biomarkers
Rachow, A., Heinrich, N., & Geldmacher, C. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.009 · Cited by 5
Montaldo, P., Lally, P., Oliveira, V., & Thayyil, S. (2018) · NeoReviews · doi:10.1542/neo.19-12-e735 · Cited by 5
Zheng, S., Qu, W., Zhang, D., Zhou, J., Xu, Y., Wu, W., Liu, C., Huang, M., Shen, E., Chen, X., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113444 · Cited by 4
“12–18 Collectively, these studies profiled whole blood or peripheral blood mononuclear cells (PBMCs) from diverse clinical conditions, encompassing different age groups (children, adolescents, and adults), infection types (LTBI and ATB), and control (noninfectious) conditions.”
Zhang, P., Zheng, J., Han, T., Ma, J., Gnanashanmugam, D., Li, M., Tang, Y., & Deng, G. (2024) · Tuberculosis · doi:10.1016/j.tube.2024.102521 · Cited by 4
Arya, R. K., Shakya, H., Biswas, V. K., Kumar, G., Yogarayan, S., Shakya, H. K., & Kim, J.-J. (2025) · Genes · doi:10.3390/genes16060716 · Cited by 4
“GSE37250 [17] and GSE39940 [18], designated as validation sets, were based on the GPL10558 platform (Illumina HumanHT-12 V4.”
New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study
Halliday, A., Jain, P., Hoang, L. T., Parker, R., Tolosa-Wright, M., Masonou, T., Green, N., Boakye, A., Takwoingi, Y., Hamilton, S., et al. (2021) · Efficacy and Mechanism Evaluation · doi:10.3310/eme08050 · Cited by 6
Self-citationChiabi, A., Wirngo, T., Bassong, P. Y., Ngoufo, F. N., Ngum, E. N., Angwafor, S. A., & Nsame, D. (2023) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2023.22228 · Cited by 4
Vito, O., Psarras, S., Syggelou, A., Wright, V., Amanatidou, V., Newton, S. M., Shailes, H., Trochoutsou, K., Tsagaraki, M., Levin, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401647 · Cited by 5
Self-citationAyalvari, S., Kaedi, M., & Sehhati, M. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02668-z · Cited by 4
“This procedure is applied to the GSE37250 [72] and the GSE39939 [72] data sets.”
BackgroundMethodEwa, A., Essiet, D. F., & Monu, S. J. U. (2015) · Journal of Tuberculosis Research · doi:10.4236/jtr.2015.33013 · Cited by 5
“87 agnosing tb from these samples, thereby creating an urgent need for improved diagnostic tests for tb in children [49].”
BackgroundFrom Transcriptomics to Biological Networks
Gurwitz, D. (2014) · Drug Development Research · doi:10.1002/ddr.21221 · Cited by 4
“For example, blood transcriptomic analysis yielded RNA expression signatures that may distinguish tuberculosis from related diseases [Anderson et al., 2014].”
BackgroundUpdate in Mycobacterium tuberculosis Lung Disease 2014
Elkington, P. T., & Zumla, A. I. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1009up · Cited by 5
Čustović, A. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23729 · Cited by 3
Xpert MTB/RIF to diagnose tuberculosis in children
Theron, G. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00111-3 · Cited by 5
Non-Gaussian Discriminative Factor Models via the Max-Margin Rank-LikelihoodPreprint
Yuan, X., Henao, R., Tsalik, E. L., Langley, R. J., & Carin, L. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1504.07468 · Cited by 4
Wang, X., VanValkenberg, A., Odom-Mabey, A. R., Ellner, J. J., Hochberg, N. S., Salgame, P. R., Patil, P., & Johnson, W. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.520627 · Cited by 4
Verrou, K., Vlachogiannis, N. I., Theofilopoulos, A. N., Tektonidou, M. G., Κόλλιας, Γ., Nikolaou, C., & Sfikakis, P. P. (2025) · Med · doi:10.1016/j.medj.2025.100840 · Cited by 4
Li, A., Bao, J., Gao, S., He, Y., Nie, X., Hosyanto, F. F., He, X., Li, T., & Xu, L. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00211 · Cited by 3
Pullen, K. M., Finethy, R., Ko, S.-H. B., Reames, C. J., Sassetti, C. M., & Lauffenburger, D. A. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00487-6 · Cited by 5
“As there have been major efforts towards identifying small gene signatures that differentiate human ATB and LTBI transcriptional responsesinthepast 25 – 31 ,wesoughttodeterminehowwellthesegenesets discriminatethe two mouse strains, C57BL/6J and C3HeB/FeJ, which are commonly utilized in unison to re…”
Mal de Pott y diagnóstico inmunológico de tuberculosis, a propósito de un caso pediátrico
Contardo, V., Cofré, J., & Hernández, P. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000200015 · Cited by 3
Translating genomics research into control of tuberculosis: lessons learned and future prospects
Warner, D. F., & Mizrahi, V. (2014) · Genome biology · doi:10.1186/s13059-014-0514-z · Cited by 4
Bachanová, P., Cheyne, A., Broderick, C. M., Newton, S. M., Levin, M., & Kaforou, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-20409-y · Cited by 3
Self-citationTuberculosis in children and adolescents: a forgotten group in a forgotten disease
López‐Varela, E., Munyangaju, I., Chabala, C., Sekadde, M. P., & Seddon, J. A. (2023) · European Respiratory Society eBooks · doi:10.1183/2312508x.10025322 · Cited by 3
Differential Expression of lncRNAs in HIV Patients with TB and HIV-TB with Anti-Retroviral Treatment
Reid, V. A., Ramos, E., Veerapandian, R., Carmona, A., Gadad, S. S., & Dhandayuthapani, S. (2024) · Non-Coding RNA · doi:10.3390/ncrna10040040 · Cited by 3
Vavougios, G. D., Zarogiannis, S. G., Krogfelt, K. A., Stamoulis, G. I., & Gourgoulianis, K. I. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101938 · Cited by 3
Loss of T cells expressing CD27 at the site of active tuberculosis – A prospective diagnostic study
Müller, C., Rumetshofer, R., Winkler, H., Bécède, M., Kneußl, M., & Winkler, S. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102009 · Cited by 3
Diagnosing Childhood Tuberculosis
Starke, J. R., & Cruz, A. T. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2020.6078 · Cited by 3
Host RNA Expression Signatures in Young Infants with Urinary Tract Infection: A Prospective Study
Dungu, K. H. S., Carlsen, E. M., Glenthøj, J. P., Schmidt, L. S., Jørgensen, I. M., Cortes, D., Poulsen, A., Vissing, N. H., Bagger, F. O., & Nygaard, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094857 · Cited by 2
“Studies have demonstrated that blood leukocytes trigger specific transcriptional responses that can be discriminated between pathogens, contributing to understanding the cellular and molecular responses that may guide targeted medical interventions [9,16–18].”
BackgroundMulti-cohort analysis reveals immune subtypes and predictive biomarkers in tuberculosis
Li, L., Wang, T., Chen, Z., Liang, J., & Ding, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-63365-5 · Cited by 4
Exploring non-sputum biosignatures for tuberculosis triage and diagnosis in children living with HIV
Kitonsa, P. J., & Jaganath, D. (2025) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2025.2595573 · Cited by 2
“In the independent test set in Kenya, the risk score achieved a sensitivity of 83% (95% Confidence Interval (CI): 69–94) and a specificity of 84% (95% CI: 75–93) to diagnose culture-confirmed TB in children [15].”
Wu, C., Xie, X., Huang, Z., Zhou, Y., Gou, Y., Du, M., Lin, H., & HUANG, J. L. (2026) · BMC Biology · doi:10.1186/s12915-026-02585-9 · Cited by 2
“Moreover, diagnostic models developed from homogeneous populations typically lack generalizability across different settings [12, 16, 32].”
Ni, R., Liu, Y., Armanni, A., Ghisleni, G., Fumagalli, S., An, Y., Li, Y., Zhuang, L., Ling, Y., Li, L., et al. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00258-25 · Cited by 4
Peritonitis tuberculosa en un niño
Daniela Arriagada, S., Neumann, M., & Donoso, A. F. (2019) · Revista chilena de infectología · doi:10.4067/s0716-10182019000600784 · Cited by 2
Parwati, I., Pitaloka, D. A. E., & Chaidir, L. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7110326 · Cited by 2
“Combining these gene expression levels successfully created an active TB disease “risk score”, as previously described in their work [28].”
Method
Metadata
- Authors
- Anderson, S. T., Kaforou, M., Brent, A. J., Wright, V. J., Banwell, C. M., Chagaluka, G., Crampin, A. C., Dockrell, H. M., French, N., Hamilton, M. S., Hibberd, M. L., Kern, F., Langford, P. R., Ling, L., Mlotha, R., Ottenhoff, T. H. M., Pienaar, S., Pillay, V., Scott, J. A. G., Twahir, H., Wilkinson, R. J., Coin, L. J., Heyderman, R. S., Levin, M., & Eley, B.
- Affiliations
- Brighton and Sussex Medical School (GB)
- Imperial College London (GB)
- Kenya Medical Research Institute (KE)
- Wellcome Trust (GB)
- University of Malawi (MW)
- University of Liverpool (GB)
- Genome Institute of Singapore (SG)
- Leiden University Medical Center (NL)
- Red Cross War Memorial Children's Hospital (ZA)
- Institute of Infectious Disease and Molecular Medicine (ZA)
- The University of Queensland (AU)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-05
- Volume
- 370
- Issue
- 18
- Pages
- 1712-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4069985
- OpenAlex
- W2145559868
- Cited by
- 379
- References
- 36
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 33 · 2023: 28 · 2022: 27 · 2021: 35 · 2020: 35 · 2019: 31 · 2018: 40 · 2017: 29 · 2016: 37 · 2015: 46 · 2014: 8
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (101113, 088316, 077092, 104803/Z/14/Z, 084679, 081697, 100714, 092654, 100890, 098532/B/12/Z, 098532, 84323, 081835, 084323)
- National Institute for Health and Care Research (NF-SI-0611-10230)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- pediatric tuberculosis, tuberculosis diagnosis, blood transcriptome, latent tuberculosis infection, HIV coinfection, culture-negative tuberculosis, Xpert MTB/RIF, sensitivity and specificity, African children
- MeSH terms
- Africa, Algorithms, Bacteriological Techniques, Child, Child, Preschool, Diagnosis, Differential, Humans, Infant, Male, Mycobacterium tuberculosis, Risk, RNA, Bacterial, Sensitivity and Specificity, Tuberculosis, HIV Infections, Oligonucleotide Array Sequence Analysis, Latent Tuberculosis, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.